#psilocybin

#psilocybin

Psilocybin and its effects on brain connectivity offer potential mental health benefits, particularly in treating depression and enhancing psychotherapy outcomes.

Psychedelics, particularly psilocybin, are under increasing study for their potential mental health benefits in a changing legal and cultural context.

Psychedelics like psilocybin may help terminal patients cope with existential distress, a concept gaining traction as research evolves.

Psychedelic experiences may be negatively impacted by clinical environments; diversity and informed consent in trials are crucial.

Microdosing truffles harnesses psilocybin to enhance mental health, creativity, and cognitive functioning while reducing symptoms of depression and anxiety.

Magic mushroom use is on the rise, but recreational use poses risks that outweigh benefits.

Magic mushrooms may have influenced the birth of human consciousness through enhanced brain connectivity and cognitive effects.

Psilocybin in magic mushrooms has a long-lasting effect on the brain, influencing space, time perception, self, and aiding in depression treatment.

York Regional Police have dismantled an illegal psilocybin operation linked to a larger network of distribution throughout Ontario.

Law enforcement seizures of psilocybin have increased nearly 3.5 times from 2017 to 2022, indicating a potential increase in availability of the substance.

Psilocybin is the most consumed plant-based psychedelic, with 11.3% of people age 12 and over reporting having ever used it in 2022.

Psychedelic drugs like psilocybin disrupt brain networks, altering space, time, and self-perception, leading to enhanced plasticity and potential therapeutic benefits for addiction or depression.

Psilocybin-induced changes in the brain's networks can provide valuable insights for further understanding its therapeutic potential.

Blocking inflammation-boosting protein IL-11 in mice leads to longer, healthier lives.

Magic mushrooms reset brain networks affecting time and self.

Psilocybin induces altered states of consciousness, enhancing sensitivity to the environment, visual disturbances, and mystical experiences in a span of 4-6 hours.

Research indicates psilocybin alters brain networks related to introspective thinking, shedding light on the neurobiological basis of psychedelic experiences.

The study of brain changes during psychedelic trances opens doors for therapeutic applications against psychiatric disorders like resistant depression and addictions.

Researchers at Washington University School of Medicine studied brain scans of participants on psilocybin, showing significant departure from normal activity patterns, offering insights for mental health disorders.

Psilocybin triggers widespread brain changes lasting weeks,